Hiring?
Logo

Nootru

Short Summary

Nootru; a medically approved consumable product designed for brain power & efficiency; an award-winning advisory board excellent for students to militaries and even for neurological rehabilitation; owns 100m+ revenue businesses; launching on 14 Jan.

Overview

Target
340'000CHF
Minimum
12'000CHF
Investment Raised
88'000CHF
Previous Rounds CHF88,000
Stage Achieving Sales
Investor Role Any

Highlights

  • Medical Doctor approved prototype formula - supported by clinical trials
  • Launching with our wholly owned, 200,000 strong community of entrepreneurs
  • Experienced team who have already built 7-Figure Brands historically
  • Award-Winning Board of Advisors running $100m+ /Year businesses
  • Supported by Tech – AI, VR, Personalisation, Apps and Big Data.
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

10% raised

Aqualution

location_on Scotland, United Kingdom

Aqualution Systems Ltd are the global leaders in the hypochlorous acid revolution. Our biocide products represent a new era in health and hygiene that harnesses HOCl, a highly effective weak acid that is naturally present in the human immune system. ...

6'300'000 CHF

Target

120'000 CHF

Min per Investor

21% raised

New Diagnostic Technology

location_on East Midlands, United Kingdom

For decades, inaccuracies in pregnancy testing have become commonplace, even though many manufacturers claim over 99% accuracy. Our patented, scientifically proven technology can eradicate this problem and will generate high returns for investors

1'200'000 CHF

Target

63'000 CHF

Min per Investor

Global Pro
0% raised

Eliminating Superbugs

location_on W. Midlands, United Kingdom

Eliminating Superbugs; 100% organic vegan health care products tested to kill antibiotic-resistant superbugs; Effective & complete microbicidal action in 10mins; First independent test results completed in DECEMBER 2018; Clinically viable product

120'000 CHF

Target

3'100 CHF

Min per Investor

load one similar proposal